![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 74050-97-8
2. Halomonth
3. Haldol Decanoate
4. Neoperidole
5. Kd 136
6. Kd 16
7. Kd-136
8. [4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] Decanoate
9. Ac20pj4101
10. R-13672
11. R-13,672
12. 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl Decanoate
13. Decanoic Acid, Ester With 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
14. Haldol Decanoas
15. Decanoic Acid, 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl Ester
16. Depot Haloperidol
17. Haloperidol Depot
18. Halomonth; Haloperidol Decanoate; Kd 136; Kd 16; Neoperidole; R 13762
19. Einecs 277-679-7
20. Haloperidol Decanoate Hcl
21. Unii-ac20pj4101
22. Haldol Dec
23. L-ornithineacetate
24. Halomonth (tn)
25. R 13672
26. Haloperidol-decanoate
27. R 13,672
28. Haloperidol Decanoate [usan:usp:ban:jan]
29. Schembl120575
30. Chembl1200986
31. Chebi:31664
32. Dtxsid50224951
33. Haloperidol Decanoate (jan/usp)
34. Haloperidol Decanoate [mi]
35. Hms3887c07
36. Haloperidol Decanoate [jan]
37. Zinc8214574
38. Haloperidol Decanoate [usan]
39. Bdbm50053408
40. Haloperidol Decanoate [mart.]
41. 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidyl Decanoate
42. Akos025392169
43. Haloperidol Decanoate [usp-rs]
44. Haloperidol Decanoate [who-dd]
45. Ks-1419
46. Ncgc00508704-02
47. Haloperidol Decanoate [ep Impurity]
48. Haloperidol Decanoate [orange Book]
49. Haloperidol Decanoate [ep Monograph]
50. Haloperidol Decanoate [usp Impurity]
51. Hy-107969
52. Cs-0031068
53. Ft-0669103
54. Haloperidol Decanoate [usp Monograph]
55. D01898
56. Q27273855
Molecular Weight | 530.1 g/mol |
---|---|
Molecular Formula | C31H41ClFNO3 |
XLogP3 | 7.9 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 16 |
Exact Mass | 529.2759000 g/mol |
Monoisotopic Mass | 529.2759000 g/mol |
Topological Polar Surface Area | 46.6 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 665 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Haloperidol decanoate |
PubMed Health | Haloperidol Decanoate (Injection) |
Drug Classes | Antipsychotic |
Drug Label | Haloperidol decanoate USP is the decanoate ester of the butyrophenone, haloperidol. It has a markedly extended duration of effect. It is available in sesame oil in sterile form for intramuscular (IM) injection. The structural formula of haloperidol d... |
Active Ingredient | Haloperidol decanoate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 50mg base/ml; eq 100mg base/ml |
Market Status | Prescription |
Company | Teva Pharms Usa; Fresenius Kabi Usa; Eurohlth Intl; Agila Speclts |
2 of 2 | |
---|---|
Drug Name | Haloperidol decanoate |
PubMed Health | Haloperidol Decanoate (Injection) |
Drug Classes | Antipsychotic |
Drug Label | Haloperidol decanoate USP is the decanoate ester of the butyrophenone, haloperidol. It has a markedly extended duration of effect. It is available in sesame oil in sterile form for intramuscular (IM) injection. The structural formula of haloperidol d... |
Active Ingredient | Haloperidol decanoate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 50mg base/ml; eq 100mg base/ml |
Market Status | Prescription |
Company | Teva Pharms Usa; Fresenius Kabi Usa; Eurohlth Intl; Agila Speclts |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)